Two Vanderbilt startups accepted in Memphis incubator

Two Vanderbilt-born startups have been accepted in the third class of the 2014 ZeroTo510 medical device accelerator in Memphis. Blood Monitoring Solutions and EndoInsight will begin the 12-week Memphis Bioworks Business Incubator next week, each receiving $50,000 in initial seed capital.

Led by a recent Vanderbilt University grad, Blood Monitoring Solutions has created a tracking system that reduces the amount blood wasted in hospitals. EndoInsight uses patented Vanderbilt University technology and provides a low-cost carbon dioxide insufflation systems intended to reduce pain associated with colonoscopies.

Two other teams, Innometrix from Oxford, Mississippi, and Compression Kinetics from Chapel Hill, N.C., have also been chosen.

Director of entrepreneurship and sustainability for Memphis Bioworks Foundation Allan Daisley said in a release the program chose to accept fewer teams into the program this year to focus on "what types of concepts and products have the greatest likelihood of emerging into our ecosystem with both the potential for follow-on funding and long-term business viability."